PharmaTimes -
May 2021
This month we celebrate women from various factions of healthcare who are all striving to achieve better outcomes for patients in their vastly different roles, showcasing their careers, interests, achievements and thoughts on the future. Turn to page 17 to meet some of the brightest stars across pharma, communications and healthcare.
With patient outcomes also clearly centre stage, on page 30 Craig Adkins says now is the time to level up care for patients with irritable bowel disorder (IBD), a condition for which there is an urgent need for a national disease strategy and the application of a standard of care across the country, while on page 34, looking at 15 years of biosimilars in Europe, Rebecca Guntern highlights that the opportunity to leverage biosimilars ‘as an obvious and sustainable way to increase patient access to medicines has never been closer’.